Skip to Navigation
Skip to Market Summary
Skip to Main Content
Skip to Related Content

Mail

Cannabis Stocks

Cannabis Stocks

40.21k followers • 23 symbols -1.90% Watchlist by Yahoo Finance

Follow this list to discover and track the stock of publicly traded companies with exposure to cannabis

23 symbols

Get the Yahoo Finance app

Free real-time data
News and price alerts
Add and edit holdings
Track performance
Create multiple watchlists

Market Realist48 minutes ago
Cronos Group: Which Firms Upgraded the Target Price?
Following Altria’s news, Cronos Group (CRON) received target price upgrades from notable investment management companies. On average, four companies (MJ) upgraded Cronos Group’s target price by nearly 70%.
Zacks3 hours ago
4 Reasons Why Pot Stocks & ETF Could Be on a High in 2019
These are the factors that could send marijuana stocks and ETF high in 2019.
Market Realist2 hours ago
Cronos Group: Optimism in the Cannabis Industry
In the last three days, Cronos Group (CRON) generated optimism in the cannabis industry (HMMJ). The market was wary about Aphria (APHA). Cronos Group’s optimism was fueled by Altria’s stake in the company.
Motley Fool2 hours ago
Here's Why Marijuana Stocks Deserve Coal in Their Stockings This Year
Pot stock investors would have had a great year, if not for this.
Market Realist3 hours ago
Canadian Cities Voted against Private Cannabis Retail Stores
On December 12, Mississauga and Markham voted against opening private cannabis retail stores for now. The Mississauga city council voted 10-2 against allowing private cannabis retail stores to operate in the city. The Markham city council voted 12-1 against opening private cannabis retail stores.
Market Realist18 hours ago
Why Green Thumb Industries’ Stock Jumped over 10% Today
Around 1:05 PM EST, the stock posted a daily high near 14.80 Canadian dollars, up 11.7% from the previous day’s closing price. Today’s sharp recovery comes as a relief for Green Thumb investors (MJ) since the stock had lost about 40.9% in the fourth quarter as of yesterday. Constellation Brands (STZ), Scotts Miracle-Gro (SMG), and Molson Coors Brewing (TAP) are down 12.5%, down 16.0%, and up 1.7% quarter-to-date, respectively.
Zacks21 hours ago
3 Pot Stocks to Watch on Farm Bill & News from Trump, May, Retail Earnings
Ryan McQueeney discusses President Trump's latest comments on the trade war and the impending vote of confidence facing U.K. Prime Minister Theresa May. He also recaps earnings results from the retail sector. Later, he highlights three cannabis stocks to watch as the farm bill passes.
Barrons.com22 hours ago
California’s Pension Fund Says No to Tobacco Stocks but Yes to Marijuana Stocks
The nation’s largest pension has mostly divested itself of tobacco and related stocks, but “Calpers” recently bought Tilray stock.
Motley Fool22 hours ago
Why New Age Beverages Stock Popped Again Today
Shares of the CBD-beverage maker rose as the Farm Bill moved closer to becoming law.
Motley Fool23 hours ago
Why Marijuana Stock GW Pharmaceuticals Dropped 10.5% in November
This marijuana stock's performance over the next few years will likely heavily hinge upon sales of the newly launched epilepsy drug Epidiolex.
Zacksyesterday
Highlighted as Zacks Bull and Bear of the Day AeroVironment, Beacon Roofing Supply, Canopy Growth and Constellation
Highlighted as Zacks Bull and Bear of the Day AeroVironment, Beacon Roofing Supply, Canopy Growth and Constellation
Zacksyesterday
Implied Volatility Surging for Cronos Group (CRON) Stock Options
Investors need to pay close attention to Cronos Group (CRON) stock based on the movements in the options market lately.
Market Realistyesterday
Here’s What Jim Cramer Had to Say about the Cronos-Altria Deal
Jim Cramer, the widely followed host of Mad Money on CNBC, gave his opinion on the deal between Cronos Group (CRON) and Altria on December 11. Cramer called Altria’s acquisition of a 45% stake in Cronos Group last week a “smart move” for Altria. This trend brings some concern for the growth trajectory of companies such as Altria.
Market Realistyesterday
New Zealand Joins the Legal Medical Cannabis Chorus
On December 11, New Zealand’s government made way for medical cannabis legalization. New Zealand already allowed a few patients to access medical cannabis. The new law makes medical cannabis widely accessible to more patients.
Market Realistyesterday
Valuations: Cannabis Companies Got Battered
In the previous part, we discussed that nine major cannabis stocks’ (HMMJ) forward EV-to-EBITDA multiples declined nearly 26% on average to 14.9x month-over-month.
Market Realistyesterday
Mavyret Is a Leading Drug in AbbVie’s HCV Franchise
AbbVie (ABBV) reported global HCV (hepatitis C) franchise sales worth $862 million in the third quarter, a YoY (year-over-year) rise of more than 100% on both an operational and a reported basis. The company reported HCV sales of $444 million in the US market, a YoY rise of more than 100%. AbbVie also reported HCV sales of $418 million in international markets in the third quarter, YoY rises of 94.5% on a reported basis and 95.6% on an operational basis.
Zacks2 days ago
Canopy Growth (CGC) Gains on Hemp Legalization, Institutional Interest
Shares of Canopy Growth (CGC) were up more than 6% in late afternoon trading Tuesday, as investors expressed optimism about the Senate's hemp legalization bill and management's comments about interest from institutional investors.
Zacks2 days ago
Gilead Sciences (GILD) Appoints Daniel O'Day as New CEO
Gilead Sciences (GILD) names Roche's Daniel O'Day as the company's new Chairman and CEO.
Motley Fool2 days ago
Why Aphria, Ascena Retail Group, and New Age Beverages Jumped Today
Find out why these stocks soared higher.
Market Realist2 days ago
Is the Latest Farm Bill a Huge Gain for the Cannabis Industry?
The new farm bill, which is expected to be voted on later this week, contained a lot of important changes. Senate Majority Leader Mitch McConnell championed the legislation for making industrial hemp legal in the United States. Legal hemp is proposed in the latest farm bill, which is expected to go to vote in the House this Wednesday, after which it is to go to the Senate.
Market Realist2 days ago
Cannabis Stocks Have Hit a Low
Earlier in this series, we saw that cannabis stocks’ (SEED) forward EV-to-sales multiples were trading at an all-time low, which was confirmed by the EV-to-EBITDA multiple in the following chart.
Simply Wall St.2 days ago
Should You Worry About Hydrogenics Corporation’s (NASDAQ:HYGS) CEO Pay?
Daryl C. Wilson has been the CEO of Hydrogenics Corporation (NASDAQ:HYGS) since 2006. This report will, first, examine the CEO compensation levels in comparison to CEO compensation at companies of Read More...
Zacks2 days ago
Bristol-Myers to Study Opdivo in Combo With Vedanta's VE800
Bristol-Myers (BMY) enters into a collaboration agreement with Vedanta Biosciences to study Opdivo clubbed with the latter's VE800 for treating patients with advanced or metastatic cancers.
Market Realist2 days ago
Venclexta: A Solid Growth Driver for AbbVie in Future Years
AbbVie (ABBV) reported global Venclexta sales worth $96 million in the third quarter, a YoY (year-over-year) rise of more than 100% on both an operational and a reported basis. As per the company’s third-quarter earnings conference call, this performance was mainly attributable to the FDA’s approval of the drug in a broader R/R (relapsed/refractory) CLL (chronic lymphocytic leukemia) indication. The company reported Venclexta sales worth $69 million in the US market, a YoY rise of more than 100%.
Market Realist2 days ago
Are Cannabis Stocks Trading Cheap?
Earlier in this series, we discussed how the average forward EV-to-sales multiple of nine Canadian cannabis (MJ) stocks were trading at an all-time low of 4.6x. Let’s look at each of the nine cannabis stocks that are part of the average multiple below.